Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5001-5050 of 6048 result(s).
CYDY CytoDyn Inc
08/01/2020 8:10:38 AM
I haven't sent him anything else. I (3)
CYDY CytoDyn Inc
08/01/2020 12:26:37 AM
Leronlimab Blockade Downregulates m (17)
CYDY CytoDyn Inc
07/31/2020 3:55:19 PM
The parent company of STAT news is (2)
CYDY CytoDyn Inc
07/31/2020 3:11:55 PM
Here is something interesting from (2)
CYDY CytoDyn Inc
07/31/2020 2:53:17 PM
NeilBob8 may have got AF's attentio (3)
CYDY CytoDyn Inc
07/31/2020 3:47:45 AM
The easiest way to take care of the (5)
CYDY CytoDyn Inc
07/31/2020 3:41:29 AM
Not an expert but let's look at it (6)
CYDY CytoDyn Inc
07/30/2020 7:02:59 AM
This injection of capital will hel (5)
CYDY CytoDyn Inc
07/29/2020 2:52:20 PM
Leukemia is a type of cancer. I jus (1)
CYDY CytoDyn Inc
07/29/2020 1:28:38 PM
That's an unusual cancer that I've (1)
CYDY CytoDyn Inc
07/29/2020 12:07:10 PM
I think leronlimab will work especi (5)
CYDY CytoDyn Inc
07/29/2020 9:48:56 AM
Thanks for the tip. Added to my ind
CYDY CytoDyn Inc
07/29/2020 1:25:34 AM
I outlined the theory for leronlima (8)
CYDY CytoDyn Inc
07/28/2020 2:57:48 PM
Went and looked up Enbrel, it's a T (2)
CYDY CytoDyn Inc
07/28/2020 1:57:35 PM
With the shares not being given for (1)
CYDY CytoDyn Inc
07/28/2020 1:16:41 PM
MD V did bring up one point that I (1)
CYDY CytoDyn Inc
07/28/2020 3:05:00 AM
Almost every LBO i've paid attentio (13)
CYDY CytoDyn Inc
07/27/2020 6:37:47 AM
For anyone worrying that the confer (4)
CYDY CytoDyn Inc
07/26/2020 4:05:04 PM
Another leronlimab path for killing (5)
CYDY CytoDyn Inc
07/24/2020 12:51:17 PM
Only a very low level of GM-CSF is (3)
CYDY CytoDyn Inc
07/24/2020 11:52:16 AM
Leronlimab already down regulates b (1)
CYDY CytoDyn Inc
07/23/2020 2:40:23 PM
In the context of a shareholder mee (3)
CYDY CytoDyn Inc
07/23/2020 6:19:00 AM
And I would hope that it would capt (2)
CYDY CytoDyn Inc
07/22/2020 12:24:10 PM
I believe this was one of ATP, CCR5 (1)
CYDY CytoDyn Inc
07/22/2020 9:43:04 AM
20% dilution is a ridiculous assert (7)
CYDY CytoDyn Inc
07/22/2020 8:06:48 AM
Not entirely useless. After listeni (12)
CYDY CytoDyn Inc
07/21/2020 8:09:57 AM
One level of progression could be t (3)
CYDY CytoDyn Inc
07/21/2020 6:41:01 AM
Probably doesn't have efficacy data (1)
CYDY CytoDyn Inc
07/21/2020 6:37:41 AM
It would have been better to write (10)
CYDY CytoDyn Inc
07/21/2020 6:19:20 AM
I've mentioned before on the board (1)
CYDY CytoDyn Inc
07/19/2020 9:23:33 PM
The dosing schedule could not be co (1)
CYDY CytoDyn Inc
07/19/2020 9:56:08 AM
Just a thought and probably absolut (5)
CYDY CytoDyn Inc
07/19/2020 2:27:33 AM
Anybody is free to do whatever they (2)
CYDY CytoDyn Inc
07/18/2020 11:58:11 PM
Because expanding the audience of p (5)
CYDY CytoDyn Inc
07/18/2020 9:23:44 PM
The PR for data should be before Dr
CYDY CytoDyn Inc
07/18/2020 1:08:47 AM
We'll see if Dr. Been asks him. ht (4)
CYDY CytoDyn Inc
07/18/2020 12:44:47 AM
They propose CXCR2 as a target of i (2)
CYDY CytoDyn Inc
07/18/2020 12:26:57 AM
I can't believe I never thought of (5)
CYDY CytoDyn Inc
07/17/2020 10:20:25 PM
Leronlimab - Disease List (currentl (23)
CYDY CytoDyn Inc
07/17/2020 1:24:52 PM
What I find odd about APN01 is that
CYDY CytoDyn Inc
07/17/2020 8:50:38 AM
Demyelination in a host of diseases (1)
CYDY CytoDyn Inc
07/17/2020 12:37:22 AM
Dr. Yo on Dr. Drew on July 21st 6 P (4)
CYDY CytoDyn Inc
07/16/2020 8:13:24 PM
The presence of peptidoglycan acti (3)
CYDY CytoDyn Inc
07/16/2020 7:55:55 PM
Here's my best guess. We know COVID (2)
CYDY CytoDyn Inc
07/16/2020 7:43:58 PM
For those touting herd immunity you (7)
CYDY CytoDyn Inc
07/16/2020 5:24:54 AM
The patient's own reservoir cells a (1)
CYDY CytoDyn Inc
07/16/2020 1:09:56 AM
that they did not investigate - I b
CYDY CytoDyn Inc
07/15/2020 5:17:01 PM
Here is a proposal I made when I wa (9)
CYDY CytoDyn Inc
07/15/2020 5:07:11 PM
By talking about the FDA positively (10)
CYDY CytoDyn Inc
07/15/2020 4:50:04 PM
The FDA is in breach of its own gui (11)
Go to page:
  • << First
  • < Previous
  • 100
  • 101
  • Next >

Recent Articles

  • Comprehensive Guide to Announcing Company Updates
  • Ray Dalio Highlights Danger of U.S. Debt Crisis Amid Growing Concerns
  • Concerns Rise as Russian Jets Intrude on NATO Airspace
  • Tesla Extends Robotaxi Tests to Arizona, Eyeing Nationwide Reach
  • Erik Siebert's Resignation Amid Pressure from Trump Administration
  • Intel's Future: A Call to Go Private and Compete in Tech
  • Elon Musk's Tesla Compensation Plan Sparks Heated Debate
  • Mark Zuckerberg on AI Spending: Opportunities Amid Risks
  • Social Security Chief Clarifies Retirement Age Comments
  • Pony.ai Launches Innovative Autonomous Vehicle Services in Singapore
  • Pony.ai Enhances Mobility Solutions with Singapore Launch
  • Xinjiang's Growth: A Bright Future Awaits Under New Strategies
  • Nexstar Broadcasting Faces Legal Action Over Labor Violations
  • Celebrating Victory: The Inaugural Más+ by Messi Tournament
  • Josys Earns Spot in 2025 Gartner Magic Quadrant for SaaS
  • V.F. Corporation Legal Action: Investors' Compensation Opportunities Await
  • Easterly ROCMuni Fund Investors Urged to Act Before Deadline
  • Important Update for Fiserv Investors on Class Action Timeline
  • Secure Your Rights as a Flywire Investor Amid Ongoing Case
  • New Visa Fee Could Shift Tech Workforce Dynamics in US
  • FAIR Advocates for Immigration Reform Through Executive Orders
  • Huawei Introduces Revolutionary Pathway and Solutions for AI
  • BNC's $250 Million Stock Buyback: A Strategic Move Forward
  • Investors Should Act Quickly: Luminar Technologies Guidance
  • Snap Inc. Shareholder Alert: Class Action Lawsuit Update
  • Investors Alert: Key Information on Dow Inc. Class Action
  • Understanding the Legal Landscape: C3.AI Investor Insights
  • Fluor Corporation Lawsuit Update: Your Rights as an Investor
  • V.F. Corporation Class Action Lawsuit and Shareholder Rights Explained
  • Kahn Swick & Foti Expands Investigation into Five Below Executives
  • Investigation Launched into Microvast's Leadership Practices
  • Concerns Grow Over Pentagon's Restrictions on Journalists
  • Investors Urged to Act on Sable Offshore Class Action Rights
  • SelectQuote Investor Alert: Class Action Deadline Approaches
  • Investors Alert: Major Legal Developments for KinderCare Shareholders
  • Exploring Machupicchu: Resumption of Tourist Activities Announced
  • Spring Bird Welcomes Charlie Conn as Customer Support Manager
  • KBR Class Action Lawsuit: Your Rights and How to Act
  • Peru Pavilion Triumphs at Expo Osaka-Kansai with Major Milestone
  • Exploring Sustainable Innovations in Agriculture: Pivot Bio's Impact
  • Ottawa Bancorp Completes Stock Repurchase Initiative Successfully
  • The Impact of School-Based Support on Student Well-Being
  • Understanding Brake Squeals: Insights for Vehicle Safety
  • Class Action Alert: KBR, Inc. Investors Should Take Note
  • EVE Energy Revolutionizes Energy Storage with 400MWh Project
  • Reinvent Telecom Leaders Highlight Cloud Experience at Navigate 25
  • EVE Energy's Landmark 400MWh Storage Project Revolutionizes Energy
  • SBS CyberSecurity's Remarkable Growth in TRAC Adoption Highlights Innovation
  • Exploring the Ongoing Investigation into RXO, Inc. Insights
  • Teamsters Push for Fair Labor Contract Amidst Kroger Negotiations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site